← FDA Drug Approvals (Drugs@FDA)
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
NDA · New Drug Application · Sponsor: MYLAN · Approved 2024-03-22
Drug application
- FDA Application #
NDA213509- Application type
- New Drug Application
- Brand name
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
- Generic name
- Efavirenz, Emtricitabine And Tenofovir Alafenamide
- Active ingredients
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN
- First approval
- 2024-03-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown